143 related articles for article (PubMed ID: 16377414)
1. Molecular strategies targeting the host component of cancer to enhance tumor response to radiation therapy.
Kim DW; Huamani J; Fu A; Hallahan DE
Int J Radiat Oncol Biol Phys; 2006 Jan; 64(1):38-46. PubMed ID: 16377414
[TBL] [Abstract][Full Text] [Related]
2. A specific antagonist of the p110delta catalytic component of phosphatidylinositol 3'-kinase, IC486068, enhances radiation-induced tumor vascular destruction.
Geng L; Tan J; Himmelfarb E; Schueneman A; Niermann K; Brousal J; Fu A; Cuneo K; Kesicki EA; Treiberg J; Hayflick JS; Hallahan DE
Cancer Res; 2004 Jul; 64(14):4893-9. PubMed ID: 15256460
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of vascular endothelial growth factor receptor signaling leads to reversal of tumor resistance to radiotherapy.
Geng L; Donnelly E; McMahon G; Lin PC; Sierra-Rivera E; Oshinka H; Hallahan DE
Cancer Res; 2001 Mar; 61(6):2413-9. PubMed ID: 11289107
[TBL] [Abstract][Full Text] [Related]
4. Effect of VEGF receptor inhibitor PTK787/ZK222584 [correction of ZK222548] combined with ionizing radiation on endothelial cells and tumour growth.
Hess C; Vuong V; Hegyi I; Riesterer O; Wood J; Fabbro D; Glanzmann C; Bodis S; Pruschy M
Br J Cancer; 2001 Dec; 85(12):2010-6. PubMed ID: 11747347
[TBL] [Abstract][Full Text] [Related]
5. SU11248 maintenance therapy prevents tumor regrowth after fractionated irradiation of murine tumor models.
Schueneman AJ; Himmelfarb E; Geng L; Tan J; Donnelly E; Mendel D; McMahon G; Hallahan DE
Cancer Res; 2003 Jul; 63(14):4009-16. PubMed ID: 12873999
[TBL] [Abstract][Full Text] [Related]
6. Differential activation of the phosphatidylinositol 3'-kinase/Akt survival pathway by ionizing radiation in tumor and primary endothelial cells.
Zingg D; Riesterer O; Fabbro D; Glanzmann C; Bodis S; Pruschy M
Cancer Res; 2004 Aug; 64(15):5398-406. PubMed ID: 15289348
[TBL] [Abstract][Full Text] [Related]
7. Combination of vascular endothelial growth factor receptor/platelet-derived growth factor receptor inhibition markedly improves radiation tumor therapy.
Timke C; Zieher H; Roth A; Hauser K; Lipson KE; Weber KJ; Debus J; Abdollahi A; Huber PE
Clin Cancer Res; 2008 Apr; 14(7):2210-9. PubMed ID: 18381963
[TBL] [Abstract][Full Text] [Related]
8. Growth factor-independent activation of protein kinase B contributes to the inherent resistance of vascular endothelium to radiation-induced apoptotic response.
Tan J; Hallahan DE
Cancer Res; 2003 Nov; 63(22):7663-7. PubMed ID: 14633687
[TBL] [Abstract][Full Text] [Related]
9. The use of tyrosine kinase inhibitors in modifying the response of tumor microvasculature to radiotherapy.
Lu B; Shinohara ET; Edwards E; Geng L; Tan J; Hallahan DE
Technol Cancer Res Treat; 2005 Dec; 4(6):691-8. PubMed ID: 16292890
[TBL] [Abstract][Full Text] [Related]
10. Triple combination of irradiation, chemotherapy (pemetrexed), and VEGFR inhibition (SU5416) in human endothelial and tumor cells.
Bischof M; Abdollahi A; Gong P; Stoffregen C; Lipson KE; Debus JU; Weber KJ; Huber PE
Int J Radiat Oncol Biol Phys; 2004 Nov; 60(4):1220-32. PubMed ID: 15519795
[TBL] [Abstract][Full Text] [Related]
11. Vasculatures in tumors growing from preirradiated tissues: formed by vasculogenesis and resistant to radiation and antiangiogenic therapy.
Chen FH; Chiang CS; Wang CC; Fu SY; Tsai CS; Jung SM; Wen CJ; Lee CC; Hong JH
Int J Radiat Oncol Biol Phys; 2011 Aug; 80(5):1512-21. PubMed ID: 21621344
[TBL] [Abstract][Full Text] [Related]
12. Novel radiosensitizers for locally advanced epithelial tumors: inhibition of the PI3K/Akt survival pathway in tumor cells and in tumor-associated endothelial cells as a novel treatment strategy?
Riesterer O; Tenzer A; Zingg D; Hofstetter B; Vuong V; Pruschy M; Bodis S
Int J Radiat Oncol Biol Phys; 2004 Feb; 58(2):361-8. PubMed ID: 14751504
[TBL] [Abstract][Full Text] [Related]
13. Vascular endothelial growth factor tyrosine kinase inhibitor AZD2171 and fractionated radiotherapy in mouse models of lung cancer.
Cao C; Albert JM; Geng L; Ivy PS; Sandler A; Johnson DH; Lu B
Cancer Res; 2006 Dec; 66(23):11409-15. PubMed ID: 17145887
[TBL] [Abstract][Full Text] [Related]
14. Endothelial survival factors as targets for antineoplastic therapy.
Reinmuth N; Stoeltzing O; Liu W; Ahmad SA; Jung YD; Fan F; Parikh A; Ellis LM
Cancer J; 2001; 7 Suppl 3():S109-19. PubMed ID: 11779081
[TBL] [Abstract][Full Text] [Related]
15. Broad spectrum receptor tyrosine kinase inhibitor, SU6668, sensitizes radiation via targeting survival pathway of vascular endothelium.
Lu B; Geng L; Musiek A; Tan J; Cao C; Donnelly E; McMahon G; Choy H; Hallahan DE
Int J Radiat Oncol Biol Phys; 2004 Mar; 58(3):844-50. PubMed ID: 14967441
[TBL] [Abstract][Full Text] [Related]
16. Phosphatidylinositol 3-kinase/Akt signaling in the response of vascular endothelium to ionizing radiation.
Edwards E; Geng L; Tan J; Onishko H; Donnelly E; Hallahan DE
Cancer Res; 2002 Aug; 62(16):4671-7. PubMed ID: 12183424
[TBL] [Abstract][Full Text] [Related]
17. Phosphatidylinositol 3-kinase/Akt signaling as a key mediator of tumor cell responsiveness to radiation.
Toulany M; Rodemann HP
Semin Cancer Biol; 2015 Dec; 35():180-90. PubMed ID: 26192967
[TBL] [Abstract][Full Text] [Related]
18. Luteolin inhibits vascular endothelial growth factor-induced angiogenesis; inhibition of endothelial cell survival and proliferation by targeting phosphatidylinositol 3'-kinase activity.
Bagli E; Stefaniotou M; Morbidelli L; Ziche M; Psillas K; Murphy C; Fotsis T
Cancer Res; 2004 Nov; 64(21):7936-46. PubMed ID: 15520200
[TBL] [Abstract][Full Text] [Related]
19. [Angiogenesis inhibitors and radiation therapy: concept and preliminary results].
Mazeron R; Bourhis J; Deutsch E
Bull Cancer; 2009 Mar; 96(3):299-310. PubMed ID: 19318308
[TBL] [Abstract][Full Text] [Related]
20. [Angiogenesis inhibitors and radiation therapy: from biology to clinical practice].
Mazeron R; Azria D; Deutsch E
Cancer Radiother; 2009 Oct; 13(6-7):568-73. PubMed ID: 19695932
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
